Showing 9791-9800 of 20328 results for "".
- Intralesional Cemiplimab Shows High Pathologic Response in Early-Stage CSCChttps://reachmd.com/news/intralesional-cemiplimab-shows-high-pathologic-response-in-early-stage-cscc/2485540/Low-dose intralesional cemiplimab produced high objective and pathologic response rates without treatment-limiting toxicity in patients with early-stage cutaneous squamous cell carcinoma (CSCC), according to “Intralesional Cemiplimab for Patients With Early-Stage Cutaneous Squamous Cell Carcinoma
- Candela Launches Glacē™ System at IMCAS Paris, Expands Portfolio with Matrix™ and Vbeam® Prohttps://reachmd.com/news/candela-launches-glace-system-at-imcas-paris-expands-portfolio-with-matrix-and-vbeam-pro/2485539/Candela debuted its latest innovation, the Glacē™ System, during the 2026 IMCAS World Congress in Paris, marking the European launch of a platform designed to elevate facial skin treatments across aesthetic and medical settings. The system, which offers both standalone and adjunctive skin purific
- The Impact of Social Media on Adolescent Mental Health: Clinical Considerations for Pediatric Practicehttps://reachmd.com/news/the-impact-of-social-media-on-adolescent-mental-health-clinical-considerations-for-pediatric-practice/2485500/New evidence links social media exposure with rising anxiety, depression, and suicidal ideation among adole
- Therapeutic Inertia in Lipid Management: Overcoming Barriers in Primary Carehttps://reachmd.com/news/therapeutic-inertia-in-lipid-management-overcoming-barriers-in-primary-care/2485502/A recent narrative review shows that many at-risk patients remain above LDL‑C targets despite clear evidence that cumulative LDL‑C exposure increases cardiovascular event risk. Therapeutic inert
- Phase 1 Trial Explores FMT–ICI Combination in mRCChttps://reachmd.com/news/phase-1-trial-explores-fmtici-combination-in-mrcc/2485507/A phase 1 clinical trial has reported that fecal microbiota transplantation (FMT) from healthy donors, when administered alongside immune checkpoint inhibitors (ICIs), was safe and potentially associa
- Environmental and Clinical Reservoirs of Antimicrobial Resistance: Implications for Genomic Surveillance and Infection Controlhttps://reachmd.com/news/environmental-and-clinical-reservoirs-of-antimicrobial-resistance-implications-for-genomic-surveillance-and-infection-control/2485487/A recent study of environmental Escherichia coli from the Juan Díaz River and Panama City wastewater influent shows high rates of ribosome‑targeting anti
- The Immune System's Role in Heart Failurehttps://reachmd.com/news/immune-systems-heart-failure/2485493/According to new research in the Journal of Molecular and Cellular Cardiology, activated helper T cells are present in failing human hearts and are strongly associated with local inflammatory, profibrotic, a
- Unraveling the Genetic and Immune Underpinnings of Allergic Conjunctivitishttps://reachmd.com/news/unraveling-the-genetic-and-immune-underpinnings-of-allergic-conjunctivitis/2485482/A large genetic study links inherited variation in immune-regulatory genes to allergic conjunctivitis, clarifying biologic pathways that shape ocular-allergy risk and of
- Impact of Sleep Position on Intraocular Pressure in Glaucoma Patients: A Novel Insighthttps://reachmd.com/news/impact-of-sleep-position-on-intraocular-pressure-in-glaucoma-patients-a-novel-insight/2485491/A recent study found that sleeping without pillows was associated with a mean 1.61 mm Hg lower nocturnal intraocular pressure (IOP) in glaucoma patients. The observational fi
- The Impact of Prenatal Environmental Exposures on Neurodevelopmenthttps://reachmd.com/news/the-impact-of-prenatal-environmental-exposures-on-neurodevelopment/2485488/New cohort data link prenatal air pollution—including black carbon and PM2.5—to lower newborn novelty preference o